Archives
-
Berberine, PPARγ, and SASP Inflammation in Atherosclerosis
2026-08-25
A 2025 study identifies an RXRα/PPARγ/NEDD4 pathway linking berberine treatment to reduced senescence-associated secretory phenotype inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of Smart-seq profiling, cellular mechanistic assays, and macrophage-specific RXRα knockdown provides a useful framework for testing nuclear-receptor control of inflammatory aging.
-
Ceapin-A7 Workflow for ATF6α-Linked ER Stress
2026-08-25
Ceapin-A7 is a selective ER stress blocker for isolating ATF6α-dependent effects without treating the entire unfolded protein response as one pathway. This practical guide applies the probe to osteonecrosis-related stress models, integrates the PTX3–TLR4/NF-κB/FGF21 findings, and provides dose, timing, storage, and troubleshooting strategies.
-
Machine Learning Prediction of mRNA Vaccine LNPs
2026-08-24
The 2022 study developed a LightGBM model that predicted mRNA vaccine lipid nanoparticle performance from 325 formulation examples, achieving an R² above 0.87. Experimental testing with MC3- and SM-102-containing particles, together with molecular dynamics modeling, showed how computational screening can prioritize formulations before extensive laboratory optimization.
-
Metal-Chelating L-Phe Nanostructures Boost ICB
2026-08-24
The reference study shows that metal-ion-chelating L-phenylalanine nanostructures can activate dendritic cells by coordinating potassium efflux, calcium influx, NLRP3 inflammasome signaling, and NF-κB activation. Combined with short-term starvation, this strategy remodeled immunosuppressive tumour microenvironments and improved immune checkpoint blockade responses in breast and colorectal tumour models.
-
Astrocytic GAT-3 in Dentate Gyrus Memory
2026-08-23
The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than merely a GABA clearance transporter. By integrating electrophysiology, optogenetics, calcium signaling analysis, immunohistochemistry, and contextual fear behavior, the authors connect GAT-3-dependent astrocyte signaling to presynaptic GluN2B-containing NMDARs and memory formation.
-
NAD+ as a Stress-Response Assay Variable
2026-08-22
Nicotinamide Adenine Dinucleotide (NAD+) is more than a redox metabolite: it can shape how researchers interpret PARP activity, protein deacetylation, autophagy, and DNA-damage responses. This article presents an assay-centered framework linking NAD+ biochemistry with caspase-dependent stress adaptation in breast cancer cells.
-
ACSL4 Drives β-Oxidation in Decidualization
2026-08-22
The reference study identifies ACSL4-driven fatty acid β-oxidation, rather than lipid droplet accumulation, as a functional metabolic requirement for endometrial decidualization. By combining human and mouse tissue analysis, endometrial stromal cell perturbation, and implantation experiments, it links lipid catabolism to decidual competence and provides a mechanistic framework for studying MPA-induced differentiation.
-
VX-661: F508del CFTR Corrector Workflows
2026-08-21
This scenario-based guide shows how VX-661 (F508del CFTR corrector), SKU A2664, can be incorporated into viability, trafficking, and chloride-channel assays without confusing functional rescue with cytotoxicity. It combines product parameters with recent evidence on variant-specific CFTR proteostasis and practical vendor-selection criteria.
-
N2703: From Nicotine Biosynthesis to Translation
2026-08-20
A mechanistic and strategic guide to using 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a defined perturbation tool, informed by new findings on nicotine biosynthesis, compartmentalized metabolism, and translational assay design.
-
FDA 2022 Drug Interaction Risk: Enzyme–Transporter Analysis
2026-08-20
This analysis of FDA New Drug Application reviews provides a mechanistic framework for interpreting enzyme- and transporter-mediated drug–drug interactions among small-molecule drugs approved in 2022. Its comparison of in vitro predictions, clinical pharmacokinetics, and labeling decisions clarifies why CYP3A and transporter liabilities remain important even when exposure changes are below twofold.
-
Biomimetic Chromatography for Pulmonary Permeability
2026-08-19
This 2024 Journal of Chromatography A study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for modelling drug–membrane partitioning and pulmonary permeability. LEKC more closely represented apparent lung permeability when phospholipid interactions were informative, whereas IAM LC offered broader compound coverage and simpler, more automation-ready analysis.
-
PBS Liposomes for Rigorous Macrophage Controls
2026-08-19
PBS Liposomes isolate the effects of liposome delivery and macrophage phagocytosis from the cytotoxic action of clodronate. This practical guide covers matched in vivo designs, assay workflows, structural-biology-informed controls, and troubleshooting strategies.
-
How Impending Cell Death Creates Metastatic States
2026-08-18
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending-death experience can acquire stable prometastatic states rather than simply recovering from injury. Their PAME–PIM model links ER stress, transcriptional reprogramming, stemness, and cytokine signaling, offering a mechanistic framework for studying how metastases originate within primary tumors.
-
CGP 55845 Hydrochloride in GABAB Assays
2026-08-18
CGP 55845 hydrochloride provides a selective way to test whether GABAB signaling shapes presynaptic release, astrocyte–neuron communication, and synaptic plasticity. This workflow translates dentate gyrus findings into practical in vitro assay design, dose selection, and troubleshooting strategies.
-
DOPE: A Lipid Bridge from Delivery to Fungal Biology
2026-08-17
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is more than a helper lipid for membrane fusion. This article examines how its phosphatidylethanolamine chemistry informs nucleic acid delivery design and the interpretation of lipid-rescue assays in Magnaporthe oryzae ferroptotic development.